Product information

Current status:

Marketed

Current status date:

2020-05-12

Original market date: ^{See footnote 1}

2016-04-13

Product name:

ACT PROGESTERONE INJECTION

Description:

MULTI DOSE VIAL

DIN:

02446820 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

68:32.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

G03DA04 PROGESTERONE

Active ingredient group (AIG) number:^{See footnote5}

0106327001